ClinicalTrials.Veeva

Menu

The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)

D

Dr. Giuseppe Fiorentino

Status

Unknown

Conditions

Bronchiectasis Adult
Lung Infection
Quality of Life
Humidifier Lung
COPD Asthma
COPD Exacerbation

Treatments

Device: High Flow Humidification

Study type

Interventional

Funder types

Other

Identifiers

NCT04142827
High Flow in Bronchiectasis

Details and patient eligibility

About

The study is intended to understand the benefit of Long Term Home care Therapy with nasal High flow in Bronchiectasis patients at home. Primary end point is to evaluate daily life compared to usual care and secondary is to evaluate the changes in lung function

Enrollment

160 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Bronchiectasis on HRCT
  • Optimization of Therapy for at least 15 days before enrollment
  • Autonomous patients with possibilities of practicing rehabilitations cycles

Exclusion criteria

  • OSAS (ODI>10/h)
  • HOME NIV
  • PH<7,35 - paO2< 60mmHg, paCo2> 55 mmHg
  • Lung cancer
  • Contraindication to high-flow nasal cannula (hfnc)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

160 participants in 2 patient groups

Therapy with high flow humidification
Experimental group
Description:
The patients will be activated after enrollment with myAirvo2 device at home for 6 months before first observations
Treatment:
Device: High Flow Humidification
Therapy with usual care
No Intervention group
Description:
The patients will be under usual care for observational

Trial contacts and locations

1

Loading...

Central trial contact

Giuseppe Fiorentino, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems